Ursprung des Netzwerks ersten Grades von Patrick Baumhof
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
15
| Public Company | Pharmaceuticals: Major | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patrick Baumhof
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Chairman Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Public Communications Contact | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
| Otto-von-Guericke-Universität Magdeburg | College/University | Doctorate Degree | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Director/Board Member | |
| University of Mannheim | College/University | Undergraduate Degree | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member | |
| Roche & Genentech, Inc. | Corporate Officer/Principal | ||
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Chief Executive Officer | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer | ||
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
| University of Bern | College/University | Doctorate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
| PIXIUM VISION | Medical Specialties | Director of Finance/CFO | |
| IPSEN | Pharmaceuticals: Major | Public Communications Contact | |
| INTEGRAGEN | Medical/Nursing Services | Chairman | |
Henogen SA
 Henogen SA Pharmaceuticals: MajorHealth Technology Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium. | Pharmaceuticals: Major | Chairman | |
Union Wallonne des Entreprises
 Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Union Wallonne des Entreprises (UWE) is an organization of private employers that aims to accelerate the creation and development of economic activity in historic Wallonia. UWE is based in Wavre, Belgium. UWE comprises thematic commissions, sectoral federations, and associated member companies. The organization provides an extranet for its members, publishes an agenda, and releases position papers. | Miscellaneous Commercial Services | President | |
| Recherche Et Industrie Therapeutiques | Chief Executive Officer | ||
| Belgian Foundation Against Cancer | Director/Board Member | ||
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman | |
| Auguria Residential Real Estate Fund (Brussels) | Director/Board Member | ||
N-Side SA
 N-Side SA Miscellaneous Commercial ServicesCommercial Services N-Side SA engages in management consulting services. The firm implements integrated software solutions to enable optimal decision-making. The company was founded by Philippe Chevalier in 2000 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| Innoste SA | Chairman | ||
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
| Hmm Consulting | Chief Executive Officer | ||
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Clark University | College/University | Masters Business Admin | |
| University of Trier | College/University | Undergraduate Degree | |
| Universität zu Köln | College/University | Doctorate Degree | |
| SYNGENTA | Chemicals: Agricultural | Corporate Officer/Principal | |
| Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | ||
| McGill University | College/University | Doctorate Degree | |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Lilly Pharma Holding GmbH | Public Communications Contact | ||
| Stadtmarketing Mannheim GmbH | Corporate Officer/Principal |
Statistik
International
| Deutschland | 25 |
| Belgien | 11 |
| Schweiz | 8 |
| Vereinigte Staaten | 5 |
| Frankreich | 4 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 56 |
| Chairman | 32 |
| Corporate Officer/Principal | 23 |
| Chief Executive Officer | 14 |
| Independent Dir/Board Member | 11 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Baron Jean Stéphenne | 36 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Klaus Schollmeier | 17 |
| Michael Brosnan | 14 |
| Debra Stephanie Barker | 11 |
| Viola Bronsema | 7 |
| Pierre Kemula | 5 |
| Sarah Fakih | 5 |
| Antony Blanc | 5 |
| Malte Greune | 5 |
| Alexander Zehnder | 4 |
| Ulrike Gnad-Vogt | 3 |
| Myriam Mendila | 3 |
| Bettina Jödicke-Braas | 1 |
- Börse
- Insiders
- Patrick Baumhof
- Unternehmensverbindungen
